Sources | Names Used |
---|---|
GDSC1000 | KIN001-260 |
PharmacoGx | KIN001-260 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SPTBN1 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
mRNA | VSIG10 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | SWT1 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.003 |
mRNA | GPR34 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.003 |
mRNA | CFAP161 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.003 |
mRNA | CSMD2 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.003 |
mRNA | SLC10A4 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | PTPN13 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | PCM1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | MTERF2 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.003 |